Structural insights into the promutagenic bypass of the major cisplatin-induced DNA lesion

scientific article published on 01 March 2020

Structural insights into the promutagenic bypass of the major cisplatin-induced DNA lesion is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1042/BCJ20190906
P698PubMed publication ID32039434

P2093author name stringSeongmin Lee
Hala Ouzon-Shubeita
Caroline K Vilas
P2860cites workOverexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugsQ24644933
Structures of DNA Polymerase β with Active-Site Mismatches Suggest a Transient Abasic Site Intermediate during MisincorporationQ27650580
DNA Polymerase   Substrate Specificity: SIDE CHAIN MODULATION OF THE"A-RULE"Q27657443
Structures of dNTP Intermediate States during DNA Polymerase Active Site AssemblyQ27672742
Binary complex crystal structure of DNA polymerase   reveals multiple conformations of the templating 8-oxoguanine lesionQ27676274
Stereospecific Formation of a Ternary Complex of (S)-α,β-Fluoromethylene-dATP with DNA Pol βQ27677140
Amino Acid Substitution in the Active Site of DNA Polymerase β Explains the Energy Barrier of the Nucleotidyl Transfer ReactionQ27678004
Structural basis of human DNA polymerase η-mediated chemoresistance to cisplatin.Q27678705
Observing a DNA Polymerase Choose Right from WrongQ27678932
Structural basis for cisplatin DNA damage tolerance by human polymerase η during cancer chemotherapyQ27678933
Metal-Dependent Conformational Activation Explains Highly Promutagenic Replication across O6-Methylguanine by Human DNA Polymerase βQ27682793
Transition-state destabilization reveals how human DNA polymerase β proceeds across the chemically unstable lesion N7-methylguanineQ27684466
Crystal structures of human DNA polymerase beta complexed with gapped and nicked DNA: evidence for an induced fit mechanismQ27742804
Enhanced expression and activity of DNA polymerase beta in human ovarian tumor cells: impact on sensitivity towards antitumor agentsQ28191144
DNA polymerase beta expression differences in selected human tumors and cell linesQ28198269
The status of platinum anticancer drugs in the clinic and in clinical trialsQ28286605
A role for DNA polymerase beta in mutagenic UV lesion bypassQ28570436
Cellular processing of platinum anticancer drugsQ29617899
Fidelity of Dpo4: effect of metal ions, nucleotide selection and pyrophosphorolysisQ33947166
Nucleotide excision repair from site-specifically platinum-modified nucleosomes.Q51836720
In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors.Q52720551
Nucleotide excision repair DNA synthesis by excess DNA polymerase beta: a potential source of genetic instability in cancer cells.Q54038050
Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta.Q54055057
Elevated DNA polymerase beta activity in a cis-diamminedichloroplatinum(II) resistant P388 murine leukemia cell line.Q54391218
The side effects of platinum-based chemotherapy drugs: a review for chemistsQ55952286
DNA repair pathways and cisplatin resistance: an intimate relationshipQ58699219
Modulation of cellular response to cisplatin by a novel inhibitor of DNA polymerase betaQ81386042
Mutagenic Replication of the Major Oxidative Adenine Lesion 7,8-Dihydro-8-oxoadenine by Human DNA PolymerasesQ92003319
Cisplatin in cancer therapy: molecular mechanisms of actionQ34098163
Factors Contributing to Aromatic Stacking in Water: Evaluation in the Context of DNA.Q34144275
C. elegans whole-genome sequencing reveals mutational signatures related to carcinogens and DNA repair deficiencyQ34350141
Error-prone translesion synthesis mediates acquired chemoresistanceQ34376054
Structural basis for the inefficient nucleotide incorporation opposite cisplatin-DNA lesion by human DNA polymerase β.Q34467599
The resurgence of platinum-based cancer chemotherapyQ34649255
Strategic down-regulation of DNA polymerase beta by antisense RNA sensitizes mammalian cells to specific DNA damaging agentsQ34774332
Molecular mechanisms of resistance and toxicity associated with platinating agentsQ35758048
Magnesium-induced assembly of a complete DNA polymerase catalytic complex.Q35792408
Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changesQ36105474
Cisplatin/carboplatin cross-resistance in ovarian cancerQ36467911
Incorrect nucleotide insertion at the active site of a G:A mismatch catalyzed by DNA polymerase betaQ36557917
Direct cellular responses to platinum-induced DNA damageQ36800400
A comprehensive survey of the mutagenic impact of common cancer cytotoxicsQ36886849
Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancersQ36958682
Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistanceQ37172320
Molecular mechanisms of cisplatin resistanceQ37926477
Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adductsQ38321258
Overexpression of DNA polymerase beta results in an increased rate of frameshift mutations during base excision repairQ40176489
Mutator phenotype of BCR--ABL transfected Ba/F3 cell lines and its association with enhanced expression of DNA polymerase betaQ40951632
The effect of DNA structure on the catalytic efficiency and fidelity of human DNA polymerase beta on templates with platinum-DNA adductsQ43548141
Loss of DNA polymerase beta stacking interactions with templating purines, but not pyrimidines, alters catalytic efficiency and fidelity.Q43833668
Involvement of DNA polymerase beta in DNA replication and mutagenic consequencesQ43876611
In vitro bypass replication of the cisplatin-d(GpG) lesion by calf thymus DNA polymerase beta and human immunodeficiency virus type I reverse transcriptase is highly mutagenicQ45770163
Overexpression of DNA polymerase β: a genomic instability enhancer processQ49816580
Acquired chemotherapy resistance in ovarian cancer.Q49896015
P275copyright licenseCreative Commons Attribution 2.0 GenericQ19125117
P6216copyright statuscopyrightedQ50423863
P433issue5
P1104number of pages15
P304page(s)937-951
P577publication date2020-03-01
P1433published inBiochemical JournalQ864221
P1476titleStructural insights into the promutagenic bypass of the major cisplatin-induced DNA lesion
P478volume477